Innovator IBD 50 ETF (FFTY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Innovator IBD 50 ETF (FFTY) trades at $41.65 with AI Score 47/100 (Grade C). Innovator IBD 50 ETF (FFTY) aims to replicate the performance of the IBD® 50 Index, which comprises the top 50 growth stocks identified by Investor's Business Daily®. Market cap: $95.78M, Sector: Unknown.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for FFTY: FFTY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FFTY against Unknown peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
FFTY: the 1 perspectives are evenly split.
How is this calculated? →Innovator IBD 50 ETF (FFTY) Business Overview & Investment Profile
Innovator IBD 50 ETF (FFTY) seeks to mirror the IBD® 50 Index, a rules-based index of 50 top growth stocks selected by Investor's Business Daily. FFTY offers investors exposure to a concentrated portfolio of companies exhibiting strong growth characteristics, within the broader market landscape.
What Is the Investment Thesis for FFTY?
The investment thesis for Innovator IBD 50 ETF (FFTY) centers on its ability to capture the performance of high-growth stocks identified by the IBD® 50 Index. Key value drivers include the index's rules-based methodology, which aims to select companies with strong earnings and price momentum. A potential catalyst is the continued outperformance of growth stocks relative to value stocks. Risk factors include the concentrated nature of the portfolio (50 stocks) and the potential for the IBD® 50 Index methodology to underperform in certain market environments. The ETF's performance is directly tied to the effectiveness of the IBD® 50 Index in identifying and selecting high-growth companies.
Based on FMP financials and quantitative analysis
FFTY Key Highlights
- FFTY invests at least 80% of its net assets in securities comprising the IBD® 50 Index, providing focused exposure.
- The IBD® 50 Index is a rules-based index compiled by Investor's Business Daily, targeting top growth stocks.
- FFTY offers a concentrated portfolio of 50 stocks, potentially leading to higher volatility.
- The ETF's performance is directly linked to the effectiveness of the IBD® 50 Index methodology.
- FFTY has a beta of 1.00, indicating market-average volatility.
Who Are FFTY's Competitors?
FFTY is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IWF iShares Russell 1000 Growth ETF | $123.00 | +1.52% | $134.15B | 44 |
| VUG Vanguard Growth ETF | $86.70 | +1.41% | $396.22B | 44 |
| QQQ Invesco QQQ Trust, Series 1 | $721.41 | +1.24% | $499.51B | 41 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FFTY's Key Strengths?
- Rules-based methodology for stock selection.
- Exposure to a concentrated portfolio of growth stocks.
- Brand recognition of the IBD® 50 Index.
- Transparent and liquid investment vehicle.
What Are FFTY's Weaknesses?
- Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Higher expense ratio compared to some broad-based growth ETFs.
What Could Drive FFTY Stock Higher?
- Continued outperformance of growth stocks relative to value stocks.
- Increased adoption of rules-based investment strategies.
- Potential changes to the IBD® 50 Index methodology.
- Launch of new IBD-linked ETFs.
What Are the Key Risks for FFTY?
- Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Competition from other growth ETFs.
- Changes in market conditions that favor value stocks.
What Are the Growth Opportunities for FFTY?
- Increased Adoption of Rules-Based Investing: The growing popularity of rules-based and algorithmic investment strategies presents a significant growth opportunity for FFTY. As investors seek systematic approaches to stock selection, the IBD® 50 Index's methodology could attract greater interest, driving increased investment in FFTY. The market for algorithmic trading is projected to reach $19.1 billion by 2030, indicating a strong tailwind for FFTY's investment approach.
- Outperformance of Growth Stocks: Periods of strong economic growth often favor growth stocks, potentially leading to increased demand for FFTY. If growth stocks continue to outperform value stocks, investors may allocate more capital to growth-focused ETFs like FFTY. Monitoring relative performance trends between growth and value stocks will be crucial in assessing this opportunity.
- Expansion of the IBD Brand: Investor's Business Daily's brand recognition and credibility could drive increased adoption of FFTY. As IBD expands its reach and influence, more investors may become aware of and interested in the IBD® 50 Index and FFTY. This expansion could involve partnerships, content marketing, or educational initiatives.
- Product Innovation: Innovator Capital Management could expand its suite of IBD-linked ETFs, offering investors a range of options with different risk and return profiles. This could include leveraged or inverse ETFs based on the IBD® 50 Index, or ETFs focused on specific sectors within the index. Product innovation could attract new investors and increase assets under management.
- Strategic Partnerships: Collaborating with financial advisors and wealth management platforms could significantly expand FFTY's distribution network. By partnering with firms that cater to growth-oriented investors, Innovator Capital Management can increase the visibility and accessibility of FFTY. This could involve offering FFTY as a core holding in model portfolios or providing educational resources to advisors.
What Opportunities Does FFTY Have?
- Increased adoption of rules-based investing.
- Outperformance of growth stocks.
- Expansion of the IBD brand.
- Product innovation and development of new IBD-linked ETFs.
What Threats Does FFTY Face?
- Competition from other growth ETFs.
- Changes in market conditions that favor value stocks.
- Underperformance of the IBD® 50 Index.
- Increased regulatory scrutiny of ETFs.
What Are FFTY's Competitive Advantages?
- Brand Recognition: The IBD® 50 Index has brand recognition through Investor's Business Daily.
- Rules-Based Methodology: The index uses a systematic approach to stock selection.
- First-Mover Advantage: FFTY was one of the first ETFs to track the IBD® 50 Index.
What Does FFTY Do?
Innovator IBD 50 ETF (FFTY) is designed to track the performance of the IBD® 50 Index. The fund was created to provide investors with a focused approach to investing in growth stocks. The IBD® 50 Index is a rules-based, computer-generated stock index compiled and published weekly by Investor's Business Daily® (IBD). This index aims to identify the top 50 growth stocks based on specific fundamental and technical criteria. FFTY invests at least 80% of its net assets, including investment borrowings, in the securities that make up the index. The ETF offers a way for investors to gain exposure to a dynamic selection of growth-oriented companies identified by IBD's proprietary methodology. The composition of the index is reviewed and rebalanced regularly, reflecting changes in market conditions and company performance, ensuring the ETF remains focused on high-growth potential stocks. FFTY provides a single investment vehicle to access a diversified portfolio of growth stocks selected using a systematic approach.
What Products and Services Does FFTY Offer?
- Tracks the performance of the IBD® 50 Index.
- Invests primarily in equity securities of companies included in the index.
- Utilizes a rules-based methodology for stock selection.
- Provides exposure to a concentrated portfolio of 50 growth stocks.
- Rebalances its portfolio regularly to reflect changes in the index.
- Offers investors a way to access a diversified basket of growth-oriented companies.
How Does FFTY Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- AUM growth is driven by investment performance and investor inflows.
- The fund's profitability is dependent on its ability to attract and retain assets.
What Industry Does FFTY Operate In?
Innovator IBD 50 ETF (FFTY) operates within the broader exchange-traded fund (ETF) market, specifically targeting growth stock investments. The ETF market has experienced significant growth in recent years, driven by increasing investor demand for diversified, low-cost investment vehicles. FFTY competes with other growth-focused ETFs, but differentiates itself through its reliance on the IBD® 50 Index, which uses a rules-based methodology to select high-growth companies. The competitive landscape includes both broad-based growth ETFs and those focused on specific sectors or investment themes.
Who Are FFTY's Key Customers?
- Retail investors seeking exposure to growth stocks.
- Financial advisors looking for diversified investment solutions.
- Institutional investors seeking to implement growth-oriented strategies.
Innovator IBD 50 ETF (FFTY) Valuation Context
Relative to its peer group, FFTY's quantitative score of 47/100 is roughly in line with the peer average of 43/100.
FFTY Financials
Bull Case vs Bear Case
Bull Case
- Rules-based methodology for stock selection.
- Exposure to a concentrated portfolio of growth stocks.
- Brand recognition of the IBD® 50 Index.
- Transparent and liquid investment vehicle.
Bear Case
- Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Higher expense ratio compared to some broad-based growth ETFs.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FFTY Latest News
No recent news available for FFTY.
FFTY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FFTY.
Price Targets
Wall Street price target analysis for FFTY.
FFTY MoonshotScore
What does this score mean?
The MoonshotScore rates FFTY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry UnknownInnovator IBD 50 ETF Unknown Stock: Key Questions Answered
What does Innovator IBD 50 ETF do?
Innovator IBD 50 ETF (FFTY) is designed to track the performance of the IBD® 50 Index, a rules-based index comprised of 50 top-ranked growth stocks selected by Investor's Business Daily (IBD). The ETF invests at least 80% of its assets in the securities that make up the index, providing investors with a concentrated portfolio of companies exhibiting strong growth characteristics. FFTY offers a way to access a diversified selection of growth stocks chosen using a systematic, data-driven approach developed by IBD.
What are the main risks for FFTY?
The main risks for FFTY include the concentrated nature of its portfolio, which can lead to higher volatility compared to more diversified ETFs. The ETF's performance is also heavily reliant on the effectiveness of the IBD® 50 Index methodology, which may underperform in certain market environments. Changes in market conditions that favor value stocks over growth stocks could also negatively impact FFTY's returns. Additionally, competition from other growth-focused ETFs could put pressure on FFTY's expense ratio and AUM.
What are the key factors to evaluate for FFTY?
Innovator IBD 50 ETF (FFTY) holds an AI score of 47/100 (low). Not financial advice.
How frequently does FFTY data refresh on this page?
FFTY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FFTY's recent stock price performance?
Innovator IBD 50 ETF (FFTY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Rules-based methodology for stock selection. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FFTY overvalued or undervalued right now?
Valuing Innovator IBD 50 ETF (FFTY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FFTY?
Before investing in Innovator IBD 50 ETF (FFTY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding FFTY to a portfolio?
Key strength of Innovator IBD 50 ETF (FFTY): Rules-based methodology for stock selection. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending and will provide further insights.
- The IBD® 50 Index methodology is proprietary and may not be fully transparent.